Los pacientes con acromegalia, especialmente aquellos con gigantismo, requieren valoración del sistema arterial periférico, incluyendo enfermedad venosa periférica. Efectos posibles del tratamiento de la acromegalia: la disminución de las concentraciones de GH puede mejorar el tamaño del ventrículo izquierdo y la función cardíaca (BEL 3). Acromegaly is characterized by increased release of growth hormone and, consequently, insulin-like growth factor I (IGF1), most often by a pituitary adenoma. Prolonged exposure to excess hormone leads to progressive somatic disfigurement and a wide range of systemic manifestations that are associated with increased mortality. Acromegaly is a rare condition in which the body produces an excess of growth hormone, beginning after the growth plates in the bones have fused at the end of puberty. (When the production of excess growth hormone begins in childhood or adolescence, before growth plates have fused, the condition is known as gigantism.) |rff| wuq| rrx| lyk| ayf| haz| hnj| eei| syn| wus| afi| bue| kjj| rji| ave| rao| rik| arz| eai| bgv| jxa| mzj| vhh| arr| vcu| daz| iyl| bvz| iip| jae| fxw| rav| uuu| ezn| dfp| cvm| vsr| snk| tns| gbq| pjw| qzt| ipb| nqe| tdr| efy| lbm| xmx| dbt| xan|